Bioconvergence of Aseptic Processing and Gene & Cell Therapy: Synergistic Advancements in Sterility and Vector Production
Event Timeslots (2)
Day 2 – Fri, February 23rd, 2024
-
Section 5: Driving Synergies Between APT and GCT
Day 2 – Fri, February 23rd, 2024
-
Section 5: Driving Synergies Between APT and GCT
GENAP Summit is a brand owned by EPM Group, registered company in Portugal. EU VAT ID PT513501312